Frozen Shoulder and Perimenopause: The Hormonal Connection Most Women Are Never Told About

Frozen shoulder is two to five times more common in women than men — and it peaks precisely during perimenopause and menopause. This is not a coincidence. Here's what declining estrogen is doing to your shoulder joint, and what natural support during this window actually looks like.

You noticed it gradually. Reaching for something on a high shelf became uncomfortable. Putting on a coat started to hurt. Then one morning you couldn't lift your arm above your head without a sharp catch of pain — and you realised this was not going away on its own.

You've been told you have frozen shoulder, or adhesive capsulitis. You've been told it affects your shoulder capsule — the connective tissue surrounding the shoulder joint — which has become inflamed, thickened, and tight. You may have been told it typically resolves in one to three years. You may have been offered steroid injections or referred to a physical therapist.

What you almost certainly weren't told is why it happened to you now, in your 40s or 50s, when you've never had a shoulder injury. And what the link between your hormonal changes and your shoulder joint actually is.

Who Is at Risk for Frozen Shoulder — And Why Women in Perimenopause Are Overrepresented

Frozen shoulder affects an estimated 2–5% of the global population each year. Among the general population, the most commonly cited risk factors include diabetes, thyroid disorders, and prolonged shoulder immobility following injury or surgery.

But there is a striking demographic pattern that doesn't fit the standard risk factors: women between the ages of 40 and 60 — precisely the perimenopause and menopause window — are disproportionately affected. Research consistently shows that frozen shoulder is significantly more common in women than men, with some studies reporting rates two to nine times higher in women during their reproductive transition years.

Hormonal changes appear to be one important contributor — and interest in this connection has grown considerably in recent years.

Perimenopause and Menopause: What Declining Estrogen Does to the Shoulder Joint

Estrogen is not simply a reproductive hormone. It plays an active role in maintaining connective tissue, regulating collagen production, and moderating the inflammatory environment in joint tissue throughout the body. Joint tissues — including the shoulder capsule — contain estrogen receptors, meaning estrogen directly influences how those tissues are maintained and repaired.

As estrogen levels fluctuate and decline during perimenopause, two specific changes occur in the shoulder joint environment:

Collagen metabolism and connective tissue maintenance are affected.

Estrogen plays an important role in collagen metabolism and connective tissue maintenance. As estrogen levels decline during perimenopause, connective tissues throughout the body may become more vulnerable to stiffness, reduced elasticity, and impaired repair processes — including in the shoulder capsule, which depends on healthy collagen to maintain its flexibility and range of motion.

Inflammatory activity in connective tissue may increase.

Estrogen has documented anti-inflammatory properties. As estrogen levels fall during the hormonal shifts of perimenopause, the inflammatory environment in joint tissue — including the shoulder capsule — becomes less regulated. The result may be a tissue environment that is more susceptible to the inflammatory and fibrotic changes associated with frozen shoulder.

A 2025 article in the Journal of Clinical Medicine specifically identified declining estrogen as a key factor in the development of frozen shoulder. A collaborative study by Duke Health researchers found that women who received hormone replacement therapy appeared less likely to develop frozen shoulder than those who did not — with HRT users showing notably lower rates of the condition in observational data.

"For many women, frozen shoulder doesn't arrive because of a shoulder injury. It arrives because the hormonal environment that was keeping the shoulder capsule flexible and less inflamed has changed."

This is why frozen shoulder in perimenopause is not just a shoulder problem. It is part of the broader pattern of musculoskeletal changes that declining estrogen drives across multiple joints simultaneously — the same mechanism behind the joint pain, stiffness, and connective tissue changes discussed in Musculoskeletal Syndrome of Menopause: The Condition Your Doctor Probably Hasn't Named Yet. It also mirrors what happens in the temporomandibular joint, where estrogen receptors in the jaw joint create the same pattern of hormonal vulnerability — as explored in Can Hormonal Changes Cause Jaw Pain? The TMJ-Estrogen Connection.

Frozen Shoulder Natural Treatment: What the Evidence Supports

Understanding that hormonal changes drive frozen shoulder changes which treatment approaches make the most sense. The standard medical approach — steroid injections, non-steroidal anti-inflammatory drugs, and physical therapy — addresses the inflammation and mobility restriction directly, but does not address the underlying connective tissue and hormonal environment that contributed to the condition developing.

Here is what the evidence supports for managing frozen shoulder alongside — or as an alternative to — medical intervention:

Physical therapy

Physical therapy is the most consistently evidenced intervention for restoring shoulder range of motion across all three stages of frozen shoulder. A physical therapist experienced in adhesive capsulitis can guide specific shoulder exercises that maintain mobility during the freezing stage, reduce stiffness during the frozen stage, and accelerate recovery during the thawing stage. Consistent physical therapy is widely recommended to help maintain mobility, improve shoulder function, and reduce the impact of daily limitations throughout the course of the condition.

Heat therapy

Applying a heating pad to the shoulder before physical therapy exercises or stretching helps relax tight connective tissue, reduces pain and stiffness, and improves the range of motion achievable during exercise. Heat is one of the most accessible and effective tools for day-to-day management of frozen shoulder pain during all stages.

Anti-inflammatory nutrition

An anti-inflammatory diet — rich in omega-3 fatty acids from oily fish, turmeric, and leafy greens — reduces the systemic inflammatory load that declining estrogen leaves unmodulated. For women where hormonal shifts are driving the shoulder capsule inflammation, nutritional anti-inflammatory support is a meaningful complement to physical therapy.

Hormone replacement therapy

For women already considering HRT for other menopausal symptoms — hot flashes, night sweats, bone density — the Duke Health findings suggest it may also reduce the risk of frozen shoulder development and progression. This is a conversation for your GP or menopause specialist, not a decision to make independently.

Corticosteroid injections

Corticosteroid injections provide significant short-term pain relief during the most acute phase of frozen shoulder and are commonly offered by orthopaedic specialists. They are most effective when combined with physical therapy — reducing pain enough to allow meaningful rehabilitation exercises.

The Natural Support Layer Most Frozen Shoulder Management Misses

Physical therapy addresses mobility. Heat addresses stiffness. Anti-inflammatory nutrition addresses systemic inflammation. What none of these directly provides is targeted connective tissue and joint support applied to the specific shoulder joint where the capsular inflammation is occurring.

This is where targeted transdermal delivery adds a practical layer. URAH is a micellar glucosamine-based range designed for transdermal application, providing localised glucosamine and Omega-3 support at the area where it is applied, without relying on traditional oral supplementation.

URAH Joint Health Omega-3 combines Omega-3 and micellar glucosamine in a formulation designed for application over the shoulder area, providing localised support at the site of use during the period of hormonal transition. For someone experiencing the morning stiffness, limited overhead reach, and night discomfort commonly associated with frozen shoulder, applying before mobility exercises and before sleep can become part of a broader shoulder-support routine.

Peer-reviewed research published in the Hong Kong Physiotherapy Journal (Onigbinde et al., 2018) demonstrated measurable improvements in joint structure and significant reductions in pain and stiffness over 12 weeks with transdermal glucosamine — with comfort improvements reported within the first four weeks.

For women where frozen shoulder is occurring alongside the broader pattern of perimenopausal bone density decline — URAH Bone Health Bio-Calcium adds transdermal bio-calcium to the glucosamine and Omega-3 base, addressing the bone dimension of the menopausal musculoskeletal transition alongside joint capsule support.

URAH is not a treatment for frozen shoulder. It is joint and connective tissue support applied during a period of hormonal transition — working alongside physical therapy and medical management, not instead of it.

Application protocol:

• Morning, before shoulder exercises: Apply URAH Joint Health Omega-3 directly over the affected shoulder — the deltoid area and the front and back of the joint. Applying before physical therapy exercises or stretching supports the connective tissue environment before mechanical demands begin.
• Midday, after prolonged overhead or reaching activity: Reapply if the shoulder has been under load.
• Night, before sleep: Final application supports overnight tissue recovery — particularly relevant for frozen shoulder, where night pain is one of the most debilitating and consistent symptoms.

For many women, frozen shoulder during perimenopause appears closely linked to the hormonal changes occurring during this stage of life — changes that may make the shoulder capsule more vulnerable to inflammation and fibrosis. Understanding the role hormonal changes may play in frozen shoulder helps explain which treatment approaches are most likely to be useful — and where targeted connective tissue support during the menopausal transition fits into the picture.

Shop URAH Joint Health Omega-3 → (for shoulder joint and connective tissue support during perimenopause and menopause) Shop URAH Bone Health Bio-Calcium → (for bone density support alongside joint health during the menopausal transition)

Frequently Asked Questions

Can menopause cause frozen shoulder? Emerging research suggests a meaningful link between the hormonal changes of perimenopause and menopause and the development of frozen shoulder. Declining estrogen levels affect collagen production and the inflammatory environment in connective tissue — both of which are directly relevant to the shoulder capsule changes that cause frozen shoulder. While there is not yet definitive proof of direct causation, women in their 40s and 50s are disproportionately affected by frozen shoulder compared to men and younger women, and the hormonal transition appears to be a significant contributing factor.

What are the best natural treatments for frozen shoulder during perimenopause? The most effective natural approach combines consistent physical therapy to maintain and restore shoulder range of motion, heat therapy before exercises to relax connective tissue, an anti-inflammatory diet rich in omega-3 fatty acids to support the joint environment, and targeted transdermal joint support applied directly to the shoulder. For women where frozen shoulder is part of a broader pattern of perimenopausal musculoskeletal symptoms, addressing the systemic hormonal dimension — through nutrition, appropriate exercise, and potentially hormone replacement therapy under medical guidance — is as important as addressing the shoulder specifically.

How long does frozen shoulder last during menopause? Frozen shoulder typically progresses through three stages — freezing, frozen, and thawing — over a period of 6 months to 3 years, though recovery timelines vary considerably. Early physical therapy is generally recommended to help preserve mobility and reduce functional limitation throughout the course of the condition. Consistent daily activity, targeted connective tissue support, and anti-inflammatory lifestyle measures may help support the recovery process during the thawing stage.

Does hormone replacement therapy help frozen shoulder? Research from Duke Health suggests that women who received HRT appeared less likely to develop frozen shoulder than those who did not. A 2025 study in animal models found that estradiol may help prevent and reduce the fibrosis associated with frozen shoulder. HRT is not specifically prescribed for frozen shoulder, but for women already managing menopausal symptoms with HRT, these findings suggest a possible additional benefit for shoulder joint health.

What is adhesive capsulitis and how is it related to perimenopause? Adhesive capsulitis is the medical term for frozen shoulder — a condition in which the connective tissue capsule surrounding the shoulder joint becomes inflamed, thickened, and tight, restricting movement and causing pain. During perimenopause, declining estrogen affects collagen metabolism and the inflammatory environment within connective tissue, which may make the shoulder capsule more vulnerable to the changes associated with adhesive capsulitis. This is why frozen shoulder is significantly more common in perimenopausal and menopausal women than in men or younger women.

References Wang Z, et al. Mechanistic insights into the anti-fibrotic effects of estrogen via the PI3K-Akt pathway in frozen shoulder. Journal of Orthopaedic Surgery and Research, 2025;20(1):1088. Saltzman E, et al. Is hormone replacement therapy associated with reduced risk of adhesive capsulitis in menopausal women? PMC, 2023. PMC10392282. Fernandes M. Adhesive capsulitis: current concepts. Journal of Clinical Medicine, 2025. doi:10.1007/s12306-025-00897-7. Chidi-Ogbolu N, et al. Effect of estrogen on musculoskeletal performance and injury risk. PMC, 2019. PMC6341375. Duke Health. Hormone therapy appears to reduce risk of shoulder pain in older women. dukehealth.org, 2022. Onigbinde AT, et al. Symptoms-modifying effects of electromotive administration of glucosamine sulphate among patients with knee osteoarthritis. Hong Kong Physiotherapy Journal, 2018;38(1):63–75.